Drug intelligence / Profile preview

Huazhong Univ. of Science and Technology AHR compound B19

Development stage
Preclinical
Lead developer
Huazhong University of Science and Technology
01

Overview

Huazhong Univ. of Science and Technology AHR compound B19: sourced facts only. name: "Among them, B19 showed low cytotoxicity (>40 μM) and potent AHR agonist activity with an EC50 value of 2.01 nM, which was 14-fold stronger than that of Tapinarof (28.93 nM)." [PMID:40924124]; target: "Among them, B19 showed low cytotoxicity (>40 μM) and potent AHR agonist activity with an EC50 value of 2.01 nM, which was 14-fold stronger than that of Tapinarof (28.93 nM)." [PMID:40924124]; developer: "Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China." [PMID:40924124]; stage: "Upon topical application, B19 significantly ameliorated imiquimod (IMQ)-induced psoriasis-like cutaneous manifestations and repaired the barrier function of skin, concurrently downregulating the expression levels of CD206, CD36, IL-18, and MCP-1." [PMID:40924124]

02

Targets

AHR (Aryl hydrocarbon receptor)

Beyond the preview

Go deeper on Huazhong Univ. of Science and Technology AHR compound B19.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huazhong Univ. of Science and Technology AHR compound B19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call